![7-(2,3-Anhydro-β-<span class="text-smallcaps">D</span>-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4…](https://static.cymitquimica.com/cas-image/167589-7-23-anhydro-b-span-class-text-smallcaps-d-span-ribofuranosyl-7h-pyrrolo-23-d-pyrimidin-4-amine.png)
CAS: 40627-31-4 - 7-(2,3-Anhydro-β-<span class="text-smallcaps">D</span>-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Fórmula:C11H12N4O3
InChI:InChI=1S/C11H12N4O3/c12-9-5-1-2-15(10(5)14-4-13-9)11-8-7(18-8)6(3-16)17-11/h1-2,4,6-8,11,16H,3H2,(H2,12,13,14)/t6-,7-,8-,11-/m1/s1
Chave InChI:InChIKey=SVPYLXNTYPUWBJ-KCGFPETGSA-N
SMILES:OCC1OC(N2C=CC=3C(=NC=NC32)N)C4OC14
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2’,3’-Anhydro-tubercidin REF: TM-TNU0416CAS: 40627-31-4 | - - - | A consultar | Sex 10 Jan 25 |
 | 2’,3’-Anhydro-7-deazaadenosine REF: 3D-NA163156CAS: 40627-31-4 | Min. 95% | A consultar | Ter 21 Jan 25 |
2’,3’-Anhydro-tubercidin
CAS:40627-31-4
Nucleoside Derivatives - 7-Deaza-purine nucleosides; Anhydro-nucleosides
Fórmula:
C11H12N4O3
Cor e Forma:
Liquid
Peso molecular:
248.24
Ref: TM-TNU0416
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 500mg | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 10 de Janeiro de 2025
2’,3’-Anhydro-7-deazaadenosine
CAS:40627-31-4
2’,3’-Anhydro-7-deazaadenosine is a modified nucleoside that is used in the treatment of viral infections. It …
Pureza:
Min. 95%
Ref: 3D-NA163156
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
